Materialise targets over 60% upside with strong medical growth, cost control, and a solid balance sheet supporting margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback